Hospitalogy’s May 2024 newsletter highlights Galenus Rx in its Innovative Startup section. Galenus Rx addresses the significant issue of unoptimized medication regimens, which cost billions in preventable adverse drug events and excess morbidity. Their platform, APPRAISE, offers advanced medication safety assessments, analyzing drug interactions down to the DNA level to provide actionable insights for safer and more effective treatment. This innovative approach aims to improve patient outcomes and reduce healthcare costs.
healthŌme and GalenusRx Forge Strategic Partnership to Launch Genomics-based Personalized Medication Safety Program
Menu
